Report ID: SQMIG35A2715
Report ID:
SQMIG35A2715 |
Region:
Global |
Published Date: December, 2024
Pages:
260
|
Tables:
94 |
Figures:
76
Globally, North America region dominated the C-reactive protein testing market with a holding of healthy market share in 2021. Early adoption of advanced technology, rising adoption of innovative devices, and continuously rising focus on clinical research are the major factors projected to drive the growth of the market in the region over the coming years. In addition, rising prevalence of cancer disease in the United States has resulted in wider use of CRP tests across the region. For instance, according to the American Cancer Society, prostate cancer emerged as the second most diagnosed cancer and third major cause of deaths in men in the United States.
Furthermore, Asia Pacific region is witnessing fastest CAGR during the forecast period owing to increased number of hospitals and rising government efforts on the development of healthcare infrastructure, especially in developing nations such as India, China, and Indonesia. In addition, a tremendous increase in the number of road accidents in the region, is also resulting in an increase in the patient population, and is anticipated to drive the growth of the regional market in the near future.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35A2715